Journal of Medical Primatology
-
Publication Venue For
- SUCCESSFUL DEVELOPMENT OF A NONHUMAN PRIMATE MODEL OF CONGENITAL CYTOMEGALOVIRUS TRANSMISSION. 43:426-426. 2014
- TARGET CELL AVAILABILITY, RATHER THAN BREAST MILK SPECIFIC FACTORS, DICTATES MOTHER-TO-INFANT TRANSMISSION OF SIV. 43:385-385. 2014
- STUDIES OF ENV-BASED RECOMBINANT IMMUNOGENS AND ROLE OF NEUTRALIZING ANTIBODY IN THE SIV MACAQUE MODEL. 40:269-270. 2011
- MOSAIC VACCINES ELICIT CD8+T CELL RESPONSES IN MONKEYS THAT CONFER IMMUNE COVERAGE OF DIVERSE HIV STRAINS. 39:282-282. 2010
- Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.. 34:226-236. 2005
- Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration.. 31:217-227. 2002
- Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge.. 31:109-119. 2002
- DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus.. 31:40-60. 2002
- Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?. 30:190-196. 2001
- Immunization against SIVmne in macaques using multigenic DNA vaccines.. 28:206-213. 1999
- Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm).. 28:97-104. 1999
- The use of a urinary estrone conjugates assay for detection of optimal mating time in the cynomolgus macaque (Macaca fascicularis).. 20:229-234. 1991
- Antibody-dependent enhancement of SIV infection: further characterization and cross reactivity between macaque and sooty mangabey isolates.. 19:269-278. 1990
- Uniocular vascular occlusion in a paraplegic hybrid monkey. A clinicopathologic study.. 4:134-142. 1975
- A vaccination regimen to enhance immune responses associated with reduced risk of mother-to-child transmission of HIV 2020
- Vaccine-elicited memory B cells expressing ADCC-mediating antibodies lacking recognition of the V2 region did not correlate with protection of NHPs 2020
- A four-fold increase in the sensitivity of the SIV viral load assay at the nonhuman primate core virology laboratory for AIDS vaccine research and development 2019
- Characterization of the CD4BS-specific neutralizing antibody response in a macaque with autologous tier 2 neutralizing antibodies 2019
- Mucosal vaccine efficacy against intrarectal SHIV acquisition independent of anti-Env antibody 2019
- A new HIV/HBV co-infection model: hepatocytic expression of human sodium taurocholate cotransporting polypeptide (NTCP) Enables Hepatitis B Virus Infection of Macaques 2018
- DNA and protein co-delivery vaccines using TLR-4-based adjuvants induce potent immune responses able to delay heterologous SIV acquisition 2018
- Impact of a TLR-5 Ligand as Adjuvant on Immunogenicity and Efficacy of a RhCMV-SIV Vaccine 2018
- Nonhuman primate models for Zika virus infection 2018
- The optimization of pediatric vaccine regimens to prevent mother-to-child transmission of HIV through breast milk 2018
- Effects of breast milk-derived non-broadly neutralizing antibodies on oral SHIV infection in infant rhesus monkeys 2017
- Molecular patterns of SHIV Env-Ab coevolution in rhesus macaques recapitulate HIV-1 Env-Ab co-evolution in humans infected by HIV-1 strains bearing homologous Envs 2017
- Molecular patterns of SHIV Env-Ab coevolution in rhesus macaques recapitulate HIV-1 Env-Ab co-evolution in humans infected by HIV-1 strains bearing homologous envs 2017
- Mucin-binding IgG: Characterizing a novel antibody effector function and discovery of a new Fc receptor 2017
- Pre-inoculation infusion with hyperimmune globulin protects against vertical transmission in the rhesus macaque model of congenital CMV infection 2017
- DNA AND PROTEIN CO-IMMUNIZATION IMPROVES THE MAGNITUDE, LONGEVITY, AND MUCOSAL DISSEMINATION OF IMMUNE RESPONSES 2015
- VACCINE-INDUCED MUCOSAL B CELLS ARE CORRELATED WITH DELAYED SIVMAC251 ACQUISITION FOLLOWING RECTAL CHALLENGE OF FEMALE BUT NOT MALE RHESUS MACAQUES 2015
- HIV ENV-SPECIFIC IGG3 RESPONSES ARE DIFFERENTIALLY ELICITED IN NONHUMAN PRIMATE BY ENV VACCINES WITH DIFFERENT ADJUVANTS 2014
- OPTIMIZATION OF SYSTEMIC AND MUCOSAL IMMUNE RESPONSES TO SIV AND HIV-1 ANTIGENS USING DIFFERENT PROTOCOLS OF DNA AND PROTEIN IMMUNIZATION IN MACAQUES 2014
- VACCINATION AGAINST MUCOSAL CHALLENGES WITH HETEROLOGOUS R5 CLADE C SHIV: PREVENTION OF INFECTION AND CORRELATES OF PROTECTION 2011
- NATURAL EVOLUTION OF CLADE C SHIV NEUTRALIZATION SENSITIVITY FROM TIER 1 TO TIER 2 IS LINKED TO DIFFERENCES IN V1 AND V2 LOOP SEQUENCES IN ENV 2010
- GM-CSF as an adjuvant for protective immune responses 2007
- Identification of ENVS that preferentially bind the cross-reactive neutralizing Ab in chronic patient sera 2007
- Mucosal aids vaccine delivered to rhesus macaques via immuno-stimulating complexes induces low levels of virus-neutralizing antibodies and cytotoxic T cell responses that are rapidly expanded upon challenge with simian-human immunodeficiency viruses (sHIVs) 2006